Drug Trial Radar · NCT02032004
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure
Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
565
Actual
Start
Mar 3, 2014
Primary completion
Jan 30, 2020
Study completion Jan 30, 2020
Sponsor
- Lead sponsor
- Mesoblast, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 9, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived mesenchymal precursor cells (MPCs \[rexlemestrocel-L\]) is effective in the treatment of chronic heart failure (HF) due to left ventricular (LV) systolic dysfunction.
Conditions
- Chronic Heart Failure
Interventions
Rexlemestrocel-LBiological
Rexlemestrocel-L consists of human bone marrow-derived allogeneic mesenchymal precursor cells (MPCs) isolated from bone mononuclear cells with anti-STRO-3 antibodies, expanded ex vivo, and cryopreserved.
Sham ComparatorOther
The sham procedure was staged to script and did not include actual cardiac mapping or delivery of rexlemestrocel-L.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Recurrent Non-fatal Decompensated Heart Failure Major Adverse Cardiac Events (HF-MACE) That Occur Prior to the First Terminal Cardiac Event (TCE)Time frame: Up to 71 months
Locations
59 sites in 2 countries. Site status is shown where the registry gives one.
Mesoblast Investigational Site 10757 - Cardiology, P.C.
Birmingham, Alabama
Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital
Birmingham, Alabama
Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center
Gilbert, Arizona
Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa
Mesa, Arizona
Mesoblast Investigational Site 10756 - Mayo Clinic
Phoenix, Arizona
Mesoblast Investigational Site 13023 - University of Arizona Medical Center
Tucson, Arizona
Mesoblast Investigational Site 10754 - University of California, San Diego
La Jolla, California
Mesoblast Investigational Site 10759 - Scripps Clinic
La Jolla, California
Mesoblast Investigational Site 13265 - University of California, Los Angeles
Los Angeles, California
Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation
Los Angeles, California
Mesoblast Investigational Site 10778 - Orange County Cardiology
Orange, California
Mesoblast Investigational Site 13031 - St. John's Regional Medical Center
Oxnard, California
Mesoblast Investigational Site 13275 - Stanford University Hospital
Stanford, California
Mesoblast Investigational Site 13267 - Bethesda Heart Hospital
Boynton Beach, Florida
Mesoblast Investigational Site 10780 - Morton Plant Hospital
Clearwater, Florida
Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida
Gainesville, Florida
Mesoblast Investigational Site 13273 - University of Florida Health
Jacksonville, Florida
Mesoblast Investigational Site 10768 - University of Miami
Miami, Florida
Mesoblast Investigational Site 13280
Orlando, Florida
Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute
Tampa, Florida
Mesoblast Investigational Site 13027 - Emory University School of Medicine
Atlanta, Georgia
Mesoblast Investigational Site 10765 - Georgia Regents University
Augusta, Georgia
Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center
Chicago, Illinois
Mesoblast Investigational Site 13030 - University of Iowa
Iowa City, Iowa
Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky
Lexington, Kentucky
Mesoblast Investigational Site 13022 - University of Louisville
Louisville, Kentucky
Mesoblast Investigational Site 13266
New Orleans, Louisiana
Mesoblast Investigational Site 10782
Boston, Massachusetts
Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute
Saginaw, Michigan
Mesoblast Investigational Site 10762 - Minneapolis Heart Institute
Minneapolis, Minnesota
Mesoblast Investigational Site 10761 - Mayo Clinic
Rochester, Minnesota
Mesoblast Investigational Site 13281
Las Vegas, Nevada
Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center
Newark, New Jersey
Mesoblast Investigational Site 10776 - Columbia University Medical Center
New York, New York
Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System
Charlotte, North Carolina
Mesoblast Investigational Site 10781 - Duke University
Durham, North Carolina
Mesoblast Investigational Site 10758 - The Christ Hospital
Cincinnati, Ohio
Mesoblast Investigational Site 10770 - University of Cincinnati
Cincinnati, Ohio
Mesoblast Investigational Site 10773
Cleveland, Ohio
Mesoblast Investigational Site 13278 - OhioHealth Research Institute
Columbus, Ohio
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.